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LONG-TERM FACIAL NERVE CLINICAL EVALUATION 
FOLLOWING VESTIBULAR SCHWANNOMA SURGERY
Rafaela Julia Batista Veronezi1, Yvens Barbosa Fernandes2, �uil�er�e Bor�es 3, Ricardo Ra�ina2
Abstract – Background: Facial function is important in accompaniment of patients operated on vestibular 
schwannoma (VS).  Objetive: To evaluate long term facial nerve function in patients undergoing VS resection 
and to correlate tumor size and facial function in a long-term follow-up.  Method: Transversal study of 20 
patients with VS operated by the retrosigmoid approach. House-Brackmann Scale was used preoperatively, 
immediately after surgery and in a long-term follow-up. Student t test was applied for statistic analysis.  Results: 
In the immediate postoperative evaluation, 65% of patients presented FP of different grades. Improvement of 
facial nerve function (at least of one grade) occurred in 53% in the long-term follow-up. There was statistically 
significant difference in facial nerve outcome in long-term follow-up when tumor size was considered (p<0.05). 
Conclusion: The majority of patients had improvement of FP in a long-term follow-up and tumor size was 
detected to be a factor associated with the postoperative prognostic.
Key wordS: vestibular schwannoma, facial nerve function, retrosigmoid approach. 
Avaliação clínica tardia do nervo facial no pós-operatório de schwannoma vestibular
Resumo – Contexto: A função facial é importante para acompanhamento dos pacientes operados de schwannoma  
vestibular (SV).  Objetivo: Avaliar o grau de paralisia facial (PF) em pacientes operados de SV, correlacionando tamanho 
do tumor com função facial na avaliação tardia.  Método: estudo transversal com análise seriada de 20 pacientes com 
SV operados pela via retrosigmóide-transmeatal. A escala de House-Brackmann foi utilizada no pré-operatório, pós-
operatório imediato e pós-operatório tardio. o teste t de Student foi aplicado para análise estatística.  Resultados: 
No pós-operatório imediato, 65% dos pacientes apresentaram graus variados de PF, sendo que 53% destes obtiveram 
melhora de pelo menos um grau de House-Brackmann na avaliação tardia. Houve diferença significativa no resultado 
da função facial no pós-operatório tardio quando o tamanho do tumor foi considerado (p<0.05).  Conclusão: A maioria 
dos pacientes da amostra apresentou melhora da PF no pós-operatório tardio, sendo o tamanho do tumor um 
fator associado ao prognóstico.
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Vestibular schwannoma (VS) is a benign tumor that 
arises from the eighth cranial nerve. It represents 8% to 
10% of all brain tumors and 80% of all cerebellopontine 
angle tumors1. In 1894, charles Balance performed the first 
successful VS excision, but the mortality rate at that time 
was devastatingly high2. Harvey cushing improved surgi-
cal techniques and brought the mortality rate down to 
approximately 20%3 performing sub-total removal of the 
tumors. Improvement in surgical techniques and develop-
ment of new technological devices had brought the mor-
tality rate to under 2%4,5. The advances and improvements 
in microsurgical techniques have changed the actual goals 
of surgery, being facial nerve preservation an utmost con-
cern3. Paralysis of the facial expression muscles is a debil-
itating and psychologically devastating condition for the 
patient. Preservation of facial nerve function after VS sur-
gery is one of the most important goals to be achieved. 
There is no established method that allows precise 
prediction of the long-term prognosis of facial nerve pal-
sy after VS surgery6-8. It has been suggested that tumor 
size is an approximate guide to predicting ultimate func-
tional outcome9,10.
The objective of this study is to analyze the facial 
nerve function in patients submitted to VS surgery by the 
retrosigmoid transmeatal approach and correlate tumor 
size with the grade of postoperative facial palsy (FP). 
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Twenty patients were enclosed in this study. They underwent 
surgical resection of VS from January 1999 to october 2002 at 
the Hospital das clínicas of the State University of campinas 
(Hc/UNIcAMP), in campinas, Brazil. 
The ethics committee on research, State University of 
campinas (UNIcAMP) - Brazil, approved the study and a free 
and informed consent was obtained from each participant.
Procedures
All patients were evaluated before surgery by computer-
ized tomography (cT) and/or magnetic resonance (Mr). Tumor 
size was considered as the largest extrameatal diameter. Tumors 
were categorized as small (≤ 2.0 cm), medium (2.1–4.0 cm) and 
large (>4.0 cm). 
The surgical standard retrosigmoid transmeatal approach was 
used in all patients by the same surgical team. The main goals of 
treatment were total removal of the tumor without major mor-
bidity and excellent preservation of facial nerve function. No 
patients were submitted to previous treatment of their tumors. 
Facial function was assessed in three specified time inter-
vals: preoperative, immediate postoperative (24 hours) and in a 
long-term follow-up (18 months or longer). It was reported us-
ing the House-Brackmann facial nerve function grading system11. 
Patients were divided into three subgroups: good facial function 
(Grades I-II), regular facial function (Grades III-IV), and poor fa-
cial function (Grades V-VI). 
Data analysis
A descriptive analysis was performed, as well as statistical 
analysis using the Student t test for independent data. Statisti-
cal significance was set at p<0.05 to determine the possible as-
sociation of the tumor size on final facial function. 
RESULTS
Fifteen patients were female (75%) and five were male 
(25%). Patients’ ages ranged from 17 to 77 years old (mean 
51 years old). Most patients (n=14) were older than 40 
years old; 40% of patients (n=8) were 40 to 60 years old 
and 30% (n=6) were older than 60 years old. There was no 
predominance regarding the side of the tumor. The mean 
tumor size was 3.38 cm with a range of 1.5 cm to 5.0 cm. 
The distribution of the tumor size is represented in Fig 1. 
The minimum follow-up was 19 months and the longest 
one was 5 years and 10 months (mean time of 3 years and 
10 months).
The evolution of facial nerve function in the three 
specified time span is illustrated in Fig 2. Three patients 
(15%) had FP preoperatively. Two of them had House-
Brackmann grade VI in this period and the other one had 
Fi� 1. Vestibular sc�wanno�a tu�or size distribution (%) in t�e 20 
patients of t�e study, considerin� t�e lar�est extra�eatal dia�eter. 
Tu�ors were cate�orized as s�all (≤ 2.0 c�), �ediu� (2.1–4.0 c�) 
and lar�e (>4.0 c�).
Fi� 2. Evolution of facial nerve function ac-
cordin� to House-Brack�ann Scale in t�e t�ree 
ti�e span: preoperative, i��ediate postoper-
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House-Brackmann grade III. These patients harbored me-
dium or large size tumors. 
The facial nerve could be anatomically preserved in 17 
patients (85%). A cable graft of sural nerve was performed 
to bridge the divided facial nerve in patients that the di-
rect suture of the facial nerve was not possible. 
A partial-to-total FP (Grades II-VI) was observed in the 
immediate postoperative course in 17 cases (85%). Nine 
patients (45%) presented poor facial function (Grades V-
VI) postoperatively, including the 3 patients who already 
presented FP preoperatively. 
In the majority of the cases FP improved in a minimum 
period of 18 months (Figs 2 and 3). In 30% of the cases (n=6), 
total restoration of facial nerve function (Grade I) was ob-
served in the long-term follow-up. In 35% (n=7), a minimal 
FP (Grade II) remained. The facial nerve function was classi-
fied as good in 13 patients (65%), regular in 4 patients (20%) 
and poor in 3 (15%). The patients with long-term poor fa-
cial function (Grade V-VI) presented FP preoperatively. 
A hypoglossal-facial nerve anastomosis12 was car-
ried out during the first year postoperative in 4 patients 
(20%) that presented no recovery of the facial function. 
A House-Brackmann grade IV was obtained in 1 case, and 
grade III in 2 cases. one patient (tumor size 5.0 cm and 
previous FP) showed no improvement of FP. For this pa-
tient plastic surgery procedures are recommended for fa-
cial function rehabilitation. 
No impairment of facial nerve deficit was observed 
in the interval between hospital discharge and follow-up 
examination. 
Facial function in long-term follow-up was also ana-
lysed with respect to tumor size (Table 1). Patients with 
regular (Grades III-IV) or poor (Grades V-VI) facial function 
had medium and large tumors, respectively. 
There was a statistically significant difference (Table 2) 
in immediate and long-term facial nerve outcome when 
the tumor size was considered. Patients who presented 
improvement of FP had smaller tumors.
DISCUSSION
VS is considered by many surgeons to be one of the 
most difficult brain tumors to be removed without addi-
tional neurologic deficits. Since the first successful resec-
tion of a VS occurred in 18942, surgical techniques have 
been continuously refined to reduce patient morbidity 
and mortality rates3,4. over the last century, treatment 
of VS has undergone immense changes and the focus of 
surgery has improved from prolongation of patient’s life 
towards preservation of cranial nerve function5, specially 
the seventh nerve. 
loss of facial nerve function is a debilitating and psy-
chologically devastating condition13. Patients with FP may 
experience several limitations as difficulty to speech and 
Fi� 3. Evaluation of facial function in t�e lon�-ter� follow-up relat-
ed to i��ediate postoperative ti�e.













I-II 4 (20) 7 (35) 2 (10) 13 (65)
III-IV 0 4  (20) 0 4 (20)
V-VI 0 0 3 (15) 3 (15)
Table 2. Mean and standard deviation of t�e tu�or size classified for i�prove�ent/no-i�-
prove�ent in lon�-ter� follow-up related to i��ediate postoperative ti�e.
Improvement Tumor size (mean, cm) Standard deviation t* p
yes (n=11) 2.90 0.78
2.355 0.030
No (n=9) 3.97 1.23
*Student t test for independent data. Statistical significance was set at p<0.05.
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eat and may experience drooling. Furthermore, these 
patients may have significant ophthalmic complications 
from loss of the blink reflex, upper and lower eyelid re-
traction, and lagophthalmos. The absence of orbicularis 
muscle tone also causes a loss of the corneal “squeegee” 
effect and predisposes the patient to dry eye symptoms 
and corneal exposure14. Socially, facial paralysis presents a 
distorted continence that others find disquieting. Affect-
ed individuals are avoided and often feel socially isolated. 
The combination of physical and psychological disabilities 
often results in a lasting postoperative depression.
The mean age of the patients of this series (51 years 
old) and the predominance of individuals of the feminine 
sex (75%) were in agreement with studies that indicate 
greater frequency of the VS in females in the fifth and 
sixth decades of life3,8,15-17.
Facial function results were reported by the House-
Brackmann facial nerve function grading system11. This 
allows for standardized comparisons of results, which is 
essential to valid medical decision making. 
Translabyrinthine, retrosigmoid transmeatal, and mid-
dle fossa approaches are the three basic approaches for 
the removal of VS. However, recent papers have recom-
mended the retrosigmoid transmeatal approach for re-
moval of VS of all sizes with no mortality and minimal 
morbidity16-21. All VS surgeries in our unit were carried out 
by this approach that presents noteworthy advantages: 
short operating time, immediate and accurate identifica-
tion of the tumor and facial nerve within the internal au-
ditory canal (IAc), possibility of facial nerve reconstruc-
tion and control of the involved neurovascular structures. 
In addition, it allows a high rate of facial nerve function 
preservation because the facial nerve is identified within 
the IAc and at brain stem and is deeper than the tumor21.
According to current literature, 8% to 20% of patients 
undergoing VS surgery experience facial nerve injury, even 
in experienced hands, despite the use of intra-operative 
facial nerve monitoring22. In this series, the intra-operative 
facial nerve injury occurred in 15% of the cases. Moreover, 
the anatomical preservation of the facial nerve indicates 
no necessarily preservation of its function23. 
The facial function immediately after VS surgery is 
extremely changeable, also being able to present itself 
without alteration. In our study, 3 patients (15%) had no 
FP in this period, but the majority of the patients (85%) 
presented some grade of facial nerve dysfunction (Grades 
II-VI). It can be caused by a number of possible mecha-
nisms24. The most common cause is direct trauma or nerve 
stretching during surgery. The facial nerve is often inti-
mately involved with the tumor, resulting in its distortion 
through compression and stretching. The severity of ad-
hesions between the tumor capsule and the facial nerve 
is highly variable15. Theoretically, both neuropraxia and 
axonotmesis are reversible phenomena and facial nerve 
function should fully return3. The involvement of the fa-
cial nerve with the tumor, either with the nerve passing 
through the tumor or with the tumor infiltrating the nerve 
sheath, was documented and graphically represented in 
the work by Sampath et al.25.
Another common mechanism of facial nerve injury is 
related to the vascular supply to the facial nerve. Main-
taining the blood suplly to the facial nerve is critical. 
Thermal injury can also cause FP. It is usually transient, 
but occasionally it may lead to local vasoconstriction and 
cause secondary ischemic injury to the nerve3. These fac-
tors can modify its functional capacity and propitiate the 
collagen deposition26.
In the recent literature, the rate of good postoperative 
function of the facial nerve (Grades I-II) in 1 year or longer 
after surgery is reported to range from 70.7% to 96%10,16,21, 
if considering any approach whatever the tumor size. The 
result obtained in the present series was 65%. However, 
the average dimension of the tumors of our series (3.38 
cm) was larger than the ones normally described in the 
literature6,8,10,15-17,20,23, and the percentage of medium and 
large tumors in our series was higher. This reflects a de-
layed diagnosis of the VS in our country. Axon et al.15 re-
ported a mean tumor size of 2.2 cm, Fenton et al.6 of 2.0 
cm, and Arts et al.20 of 0.89 cm. In the study of Zaouche 
et al.8 only 10.2% of patients had large tumors. The status 
of good facial nerve function when considering tumors 
extending more than 3.1 cm in the series of wiet et al.10 
was 61%, a percentage very next to our index of 65%. 
The prognostic factors of postoperative FP in VS sur-
gery have been variously reported6-8,27. Although tumor size 
alone should not be considered as a predictive factor, it 
has been thought to be the most important one9,10. Gorm-
ley28 showed that 96% of patients with small tumors had 
postoperatively normal facial function or slight dysfunc-
tion (Grade I-II), whereas only 38% of patients with tumors 
greater than 4.0 cm had no dysfunction. Mamikoglu et al.18 
reported that 45% of patients with tumors greater than 
3.0 cm had House-Brackmann grade I-II, 34% had House-
Brackmann grade III-IV, and 20% had House-Brackmann 
grade V-VI facial function at 1-year follow-up. lanman et 
al.29 reported that 48% of patients with large tumors (>3.0 
cm) had poor facial nerve function at 1-year after sur-
gery. Usually, favorable facial nerve function is achieved 
in an average of only 50% of patients with large VS oper-
ated on by the most experienced teams19. Mcelveen et 
al.23 showed that 56% of patients had House-Brackmann 
grade I-II at 1-year follow-up in tumors larger than 4.0 cm. 
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In our series tumor size proved to be an important 
variable on outcome in the long-term follow-up. Statisti-
cal significance (p<0.05) was demonstrated in compari-
son to immediate postoperative results, showing that a 
large tumor is associated with poorer postoperative facial 
nerve function (Table 2). 
Facial nerve can tolerate a large degree of stretching, 
compression or distortion, which is caused by the tumor, 
without apparent FP. However, as the tumor grows, the 
individual fibers of the facial nerve may become splayed 
over the tumor capsule. Not surprisingly, very large tumors 
place the nerve under greater tension, which increases the 
likelihood of stretch injury and may explain the high rate 
of FP seen in patients with large tumors27. Alternatively, 
nerve dysfunction may result from poor vascularization of 
nerve segments that are effaced by large tumors. 
It would appear that the bigger is the tumor the great-
er is the risk to the nerve. However, size cannot predict 
the relationship or invasiveness of the tumor with regard 
to the nerve, the degree of adhesiveness, or the difficulty 
of dissection6. The facial nerve can traverse any part of 
the tumor capsule and even pass through the tumor itself, 
and this occurs equally in small and large tumors25.
Patients with preoperative facial weakness had a poor-
er prognosis in terms of facial nerve function following 
VS surgery7. This also could be observed in our series. It 
may be due to infiltration of the facial nerve by the VS, 
especially if the tumor is large30. 
In conclusion, in spite of the large develpments in VS 
surgery in the last century, FP remains a frequent compli-
cation. The majority of the patients of this study present-
ed improvement of the FP in an average time of 3 years 
and 10 months (65%). It was clear that it is possible to 
obtain normal to near-normal facial function in patients 
operated on by retrosigmoid transmeatal approach. Tu-
mor size was a significant factor for postoperative facial 
nerve function in a long-term follow-up. This is consistent 
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